GlobeMed Pharma Group

Providers of Pharmaceutical API

We are a research-focused pharmaceutical API company committed to driving innovation from seed to sale, specializing in the development of genetically advanced and modified plants with enhanced cannabinoid content while staying at the forefront of chemical and pharmaceutical advancements.

Driving innovation and clinical excellence to transform patient health and wellbeing.

As a GMP-certified pharmaceutical company, we specialize in the production of Active Pharmaceutical Ingredients (APIs) for medicinal applications. Our expertise is rooted in advancing the science of medicinal cannabis by refining the plant into premium extracts and pure active compounds that meet the highest industry standards.

Our Services

Comprehensive Solutions

We excel in fulfilling all your custom synthesis requirements, ensuring a seamless progression from development to commercial-scale manufacturing.

Specialize in the production of premium-quality cannabinoid isolates and dry extracts for medicinal use. Our isolates deliver up to 99.7% purity, while our dry extracts represent a time-honored, solvent-free form of concentrated cannabinoids.

Our advanced R&D center harness expertise in complex chemistry to master intricate processes.


Stay up to date. In our newsletter we will inform you about our latest findings and developments. You will also gain exciting insights into our daily work.